Evidence map›Paper›PMID 40982020›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

The diagnostic value of 18 F-FAPI-04 PET/CT in unresectable hepatocellular carcinoma: a head-to-head comparison with 18 F-FDG PET/CT.

Huanyu Gong, Yong Cheng, Qiang Li, Yingjun He, Qijun Cai, Yongjin Tang, Yulong Liu, Lu Kuang, Yingxin Li, Jingjie Shang and 6 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Huanyu Gong *Department of Nuclear Medicine, The First Affiliated Hospital of Jinan University, No. 613 West Huangpu Road, Guangzhou, 510630, Guangdong Province, China.
Yong Cheng *Department of Nuclear Medicine, The First Affiliated Hospital of Jinan University, No. 613 West Huangpu Road, Guangzhou, 510630, Guangdong Province, China.
Qiang Li *Department of Hepatobiliary Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province, China.
Yingjun HeDepartment of Nuclear Medicine, The First Affiliated Hospital of Jinan University, No. 613 West Huangpu Road, Guangzhou, 510630, Guangdong Province, China.
Qijun CaiDepartment of Nuclear Medicine, The First Affiliated Hospital of Jinan University, No. 613 West Huangpu Road, Guangzhou, 510630, Guangdong Province, China.
Yongjin TangDepartment of Nuclear Medicine, The First Affiliated Hospital of Jinan University, No. 613 West Huangpu Road, Guangzhou, 510630, Guangdong Province, China.
Yulong LiuDepartment of Interventional Vascular Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province, China.
Lu KuangDepartment of Nuclear Medicine, The First Affiliated Hospital of Jinan University, No. 613 West Huangpu Road, Guangzhou, 510630, Guangdong Province, China.
Yingxin LiDepartment of Nuclear Medicine, The First Affiliated Hospital of Jinan University, No. 613 West Huangpu Road, Guangzhou, 510630, Guangdong Province, China.
Jingjie ShangDepartment of Nuclear Medicine, The First Affiliated Hospital of Jinan University, No. 613 West Huangpu Road, Guangzhou, 510630, Guangdong Province, China.
Chengzhi LiDepartment of Interventional Vascular Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province, China.
Kangshou LiuDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province, China.
Mingrong CaoDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province, China.
Lu WangDepartment of Nuclear Medicine, The First Affiliated Hospital of Jinan University, No. 613 West Huangpu Road, Guangzhou, 510630, Guangdong Province, China. l_wang1009@foxmail.com.
Xueying LingDepartment of Nuclear Medicine, The First Affiliated Hospital of Jinan University, No. 613 West Huangpu Road, Guangzhou, 510630, Guangdong Province, China. lingxuey@163.com.
Hao XuDepartment of Nuclear Medicine, The First Affiliated Hospital of Jinan University, No. 613 West Huangpu Road, Guangzhou, 510630, Guangdong Province, China. txh@jnu.edu.cn.ORCID 0000-0002-6199-3929

Funding

Yttrium Little Red Flower Health Fund Project of Sunshine Medical and Health Development Foundation in Henan Province, China No. HKP2024002
6 · The paper itself

Abstract

purposesThis study aimed to evaluate the diagnostic value of

methodsPatients with uHCC who underwent paired

resultsEighty-five patients (mean age: 53.9 ± 10.0 years) were included. In patient-based analysis,

conclusions

Indexed as

Carcinoma, HepatocellularFluorodeoxyglucose F18Liver NeoplasmsPositron Emission Tomography Computed TomographyAdultAgedFemaleHumansMaleMiddle AgedRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18RadiopharmaceuticalsFluorodeoxyglucoseInhibitor of fibroblast activation proteinPositron emission tomographyUnresectable hepatocellular carcinoma

Identifiers

PMID40982020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.